Nantahala Capital Management, LLC Q2 2021 Filing

Filed August 16, 2021

Portfolio Value

$3.5B

Holdings

116

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (116 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	—HTG MOLECULAR DIAGNOSTICS IN	363,622	$2.1M	0.06%
102	—5 01 ACQUISITION CORP	186,650	$1.9M	0.05%
103	—ANGION BIOMEDICA CORP	125,000	$1.6M	0.05%
104	—TELIGENT INC NEW	2,418,987	$1.3M	0.04%
105	—METROMILE INC	558,296	$1.2M	0.04%
106	—KINTARA THERAPEUTICS INC	523,279	$1.2M	0.03%
107	—SUSTAINABLE OPPORTNTS ACQ CO	802,758	$1.2M	0.03%
108	—PERELLA WEINBERG PARTNERS	400,000	$1.1M	0.03%
109	PAYOPAYONEER GLOBAL INC	333,327	$790K	0.02%
110	IMTXIMMATICS N.V	226,471	$779K	0.02%
111	BOLT1EURBOLT BIOTHERAPEUTICS INC	50,000	$773K	0.02%
112	—CYREN LTD	598,540	$485K	0.01%
113	MDIAMEDIACO HLDG INC	103,680	$373K	0.01%
114	SIGASIGA TECHNOLOGIES INC	49,605	$312K	0.01%
115	—FALCON MINERALS CORP	878,022	$167K	0.00%
116	—AVENUE THERAPEUTICS INC	30,211	$76K	0.00%

PreviousPage 2 of 2